Hurley Capital »

Catalyst Pharmaceutical Partners shares owned by Hurley Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Hurley Capital from 13F filings

Historical chart of Hurley Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Hurley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Hurley Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $21 1 21.00

More positions owned by Hurley Capital

Vanguard Value ETF Uit Exchange Traded (VTV)
Vanguard Russell Uit Exchange Traded (VONG)
Vanguard Govt Bond ETF Uit Exchange Traded (VGIT)
Ishares Ibonds 2025 Term Uit Exchange Traded (IBHE)
Sprott Physical Silver TRUST Trust Unit Common Stock (PSLV)
Vanguard S&P 500 ETF Uit Exchange Traded
Enterprise Prd Prtnrs Common Stock (EPD)
Technology Select Sector Uit Exchange Traded (XLK)
Ishares Ibnd 2026 Trm Hg Uit Exchange Traded (IBHF)
Schwab International Uit Exchange Traded (SCHF)
Alphabet Inc Class A Common Stock (GOOGL)
Morgan Stanley Common Stock (MS)
Schwab US Large Cap Etf Uit Exchange Traded (SCHX)
Schwab US Large Cap Uit Exchange Traded (SCHG)
Blackstone Group Common Stock

View all positions for Hurley Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Dimensional Fund Advisors
Pacer Advisors
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
First Trust Advisors
Morgan Stanley
Royce & Associates
Bank of America Corporation
Northern Trust
Nuveen Asset Management

View all funds holding Catalyst Pharmaceutical Partners